未登录Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101EGFR WT晚期/转移性非鳞非小细胞肺癌的真实世界治疗与结局:LUMINATE-101项目的合并分析
Girard, Nicolas; Xu, Qingqing; Camidge, D. Ross; Baijal, Shobhit; Ng, Sophia; Kamalakar, Rajesh; Ratajczak, Christine; Alhasani, Hasan; Crawford, Samuel; Karve, Sudeep
分享
收藏Patient-reported outcomes (PROs) in the LUMINOSITY trial: Evaluating telisotuzumab vedotin (Teliso-V) in patients (Pts) with c-Met protein overexpressing (OE), EGFR wildtype, non-squamous non-small cell lung cancer (NSQ NSCLC)LUMINOSITY试验中的患者报告结局(PROs):评估telisotuzumab vedotin(Teliso-V)在c-Met蛋白过表达(OE)、EGFR野生型、非鳞非小细胞肺癌(NSQ NSCLC)患者(Pts)中的应用
Girard, N.; Lu, S.; Bar, J.; Xu, Q.; Ng, S.; Sen, R.; Majd, Z.; Nsiah, I.; Ratajczak, C.; Xia, M. S.; Karve, S.; Camidge, D. R.
分享
收藏LUMINATE-103: Real-world treatment patterns and outcomes of patients (pts) with epidermal growth factor receptor mutant (EGFR MU), non-squamous (NSQ) locally advanced/metastatic non-small cell lung cancer (a/mNSCLC): Pooled analysis of large US electronic health record (EHR) datasets
Cho, B. C.; Xu, Q.; Ng, S.; Goldman, J. W.; Girard, N.; Planchard, D.; Baijal, S.; Kamalakar, R.; Blot, V.; Alhasani, H.; Karve, S.; Lu, S.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏A novel oncologist-led BRCA1/2 germline mutation (gBRCAm) testing and counselling model for patients with ovarian cancer: Interim results from the ENGAGE (NCT02406235) study
Scambia, G.; Chalas, E.; Huang, G.; Grana Suarez, B.; Gonzalez-Santiago, S.; Colombo, N.; Pignata, S.; Huot-Marchand, P.; Karve, S.; Blakeley, C.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏